Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials

BACKGROUND: The efficacy and safety of bivalirudin (Biva) versus heparin in patients with diabetes mellitus (DM) who undergo percutaneous coronary intervention (PCI) remain controversial. Our meta-analysis was undertaken to evaluate the efficacy and safety of Biva compared with those of heparin in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Juan, Yang, Xinchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521879/
https://www.ncbi.nlm.nih.gov/pubmed/28723739
http://dx.doi.org/10.1097/MD.0000000000007204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521879/
https://www.ncbi.nlm.nih.gov/pubmed/28723739
http://dx.doi.org/10.1097/MD.0000000000007204

Ejemplares similares